My Hep Sofosbuvir Tablets 400 mg

  • Product Name : My Hep Sofosbuvir Tablets 400 mg
  • Category : Antiviral
  • Manufacturer Name : Mylan
  • Trade Name : My Hep
  • Available Dosage : 400 mg
  • Packing : Bottle
  • Pack Insert/Leaflet : 1 Pack/28 Tablets
  • Ingredients : Sofosbuvir
  • Formulation : Tablet
  • Therapeutic use : to treat chronic (long-lasting) hepatitis C, a viral infection of the liver
  • Production Capacity : 100000

Description:-

Introduction to My Hep Sofosbuvir Tablets 400 mg

My Hep contains 400 mg of sofosbuvir, a potent antiviral drug used in the management of chronic hepatitis C virus (HCV) infection. Sofosbuvir works by targeting the hepatitis C virus's ability to replicate, leading to a reduction in viral load and improvement in liver function.


Uses of My Hep Sofosbuvir Tablets 400 mg

Chronic Hepatitis C Treatment: Utilized in combination with other antiviral medications to treat chronic hepatitis C infection.

HCV Genotype Treatment: Effective against various genotypes of the hepatitis C virus, enhancing treatment flexibility.

Prevention of Liver Damage: Helps to reduce the progression of liver damage caused by hepatitis C infection.


Benefits of My Hep Sofosbuvir Tablets 400 mg

Effective Viral Suppression: Provides strong antiviral activity that can significantly reduce the viral load in the body.

Improved Liver Function: Aids in reducing liver inflammation and damage associated with hepatitis C.

Combination Therapy: Can be used in combination with other antiviral agents for a more comprehensive treatment approach.

Convenience: Administered as a tablet, making it easier for patients to adhere to the treatment regimen.


Mechanism of Action of My Hep Sofosbuvir Tablets 400 mg

NS5B Polymerase Inhibitor: Sofosbuvir is a nucleotide analog that inhibits the NS5B polymerase enzyme, essential for the replication of the hepatitis C virus.

Viral Replication Disruption: By interfering with the viral RNA polymerase, sofosbuvir prevents the replication of the hepatitis C virus, leading to a reduction in viral load.

Direct Antiviral Activity: Targets the hepatitis C virus directly, leading to improved outcomes in managing chronic infection.